Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-26 to 2024-02-27
Current total value of award: $297.54
Description: 4563818379!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML